Trial intelligence / Profile preview

Dinoprostone for Blood Loss Reduction in Abdominal Hysterectomy

NCT04080323Phase 3Completed

Sponsor
Cairo University
Start
Sep 2019
Primary completion
May 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dinoprostone in Uterine Fibroids (UF), adenomyosis, Abnormal uterine bleeding (AUB), sponsored by Cairo University. Started Sep 2019; status: completed.

02

Drugs

dinoprostone
03

Conditions

Uterine Fibroids (UF)adenomyosisAbnormal uterine bleeding (AUB)

Beyond the preview

Go deeper on NCT04080323.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04080323.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call